News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ikonisys Inc. Reports Positive Results from Clinical Study Designed to Evaluate the Efficacy of Circulating Tumor Cell Detection with Ikonisys' Automated Microscope


10/14/2008 7:55:54 AM

NEW HAVEN, Conn., Oct 14, 2008 (BUSINESS WIRE) -- Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, today announced positive results from a clinical study conducted by a research group at the Weatherall Institute of Molecular Medicine at Oxford University, a laboratory supported by Cancer Research U.K. (CRUK), the country's leading cancer charity. The study validates the company's CellOptics(R) platform and proprietary digital microscope, the Ikoniscope(R), as a viable method for quickly and easily detecting and detailing circulating tumor cells (CTC) in the blood. The findings, published in the British Journal of Cancer (September 2008), represent a significant milestone for screening and disease monitoring for a variety of cancers, including prostate, colorectal and ovarian.

Read at Market Watch

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES